Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates

Bioorg Med Chem. 2018 Apr 1;26(7):1275-1284. doi: 10.1016/j.bmc.2017.06.043. Epub 2017 Jun 28.

Abstract

Biocatalysis has been increasingly used for pharmaceutical synthesis in an effort to make manufacturing processes greener and more sustainable. Biocatalysts that possess excellent activity, specificity, thermostability and solvent-tolerance are highly sought after to meet the requirements of practical applications. Generating biocatalysts with these specific properties can be achieved by either discovery of novel biocatalysts or protein engineering. Meanwhile, chemoenzymatic routes have also been designed and developed for pharmaceutical synthesis on an industrial scale. This review discusses the recent discoveries, engineering, and applications of biocatalysts for the synthesis of pharmaceuticals and pharmaceutical intermediates. Key classes of biocatalysts include reductases, oxidases, hydrolases, lyases, isomerases, and transaminases.

Keywords: Biocatalysis; Hydrolases; Isomerases; Lyases; Oxidases; Pharmaceutical intermediates; Pharmaceuticals; Reductases; Transaminases.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biocatalysis
  • Humans
  • Hydrolases / metabolism*
  • Isomerases / metabolism*
  • Lyases / metabolism*
  • Oxidoreductases / metabolism*
  • Pharmaceutical Preparations / chemistry
  • Pharmaceutical Preparations / metabolism*
  • Protein Engineering
  • Transaminases / metabolism*

Substances

  • Pharmaceutical Preparations
  • Oxidoreductases
  • Transaminases
  • Hydrolases
  • Lyases
  • Isomerases